FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201248840> ?p ?o ?g. }

• W3201248840 endingPage "e1003801" @default.
• W3201248840 startingPage "e1003801" @default.
• W3201248840 abstract "Background Dementia onset in those aged <65 years (young onset dementia, YOD) has dramatic individual and societal consequences. In the context of population aging, data on YOD are of major importance to anticipate needs for planning and allocation of health and social resources. Few studies have provided precise frequency estimates of YOD. The aim of this study is to provide YOD prevalence and incidence estimates in France and to study the contribution of comorbidities to YOD incidence. Methods and findings Using data from the French national health data system (Système National des Données de Santé, SNDS) for 76% of the French population aged 40 to 64 years in 2016 ( n = 16,665,795), we identified all persons with dementia based on at least 1 of 3 criteria: anti-Alzheimer drugs claims, hospitalization with the International Classification of Diseases-10th Revision (ICD-10) dementia codes (F00 to F03, G30, G31.0, G31.1, or F05.1), or registration for free healthcare for dementia. We estimated prevalence rate (PR) and incidence rate (IR) and estimated the association of comorbidities with incident YOD. Sex differences were investigated. We identified 18,466 (PR standardized = 109.7/100,000) and 4,074 incident (IR standardized = 24.4/100,000 person-years) persons with prevalent and incident YOD, respectively. PR and IR sharply increased with age. Age-adjusted PR and IR were 33% (95% confidence interval (CI) = 29 to 37) and 39% (95% CI = 31 to 48) higher in men than women ( p < 0.001 both for PR and IR). Cardio- and cerebrovascular, neurological, psychiatric diseases, and traumatic brain injury prevalence were associated with incident YOD (age- and sex-adjusted p -values <0.001 for all comorbidities examined, except p = 0.109 for antihypertensive drug therapy). Adjustment for all comorbidities explained more than 55% of the sex difference in YOD incidence. The lack of information regarding dementia subtypes is the main limitation of this study. Conclusions We estimated that there were approximately 24,000 and approximately 5,300 persons with prevalent and incident YOD, respectively, in France in 2016. The higher YOD frequency in men may be partly explained by higher prevalence of cardiovascular and neurovascular diseases, substance abuse disorders, and traumatic brain injury and warrants further investigation." @default.
• W3201248840 created "2021-09-27" @default.
• W3201248840 creator A5010335262 @default.
• W3201248840 creator A5025485223 @default.
• W3201248840 creator A5041882778 @default.
• W3201248840 creator A5058392597 @default.
• W3201248840 date "2021-09-23" @default.
• W3201248840 modified "2023-10-10" @default.
• W3201248840 title "Prevalence and incidence of young onset dementia and associations with comorbidities: A study of data from the French national health data system" @default.
• W3201248840 cites W1509544343 @default.
• W3201248840 cites W1520845903 @default.
• W3201248840 cites W1562946553 @default.
• W3201248840 cites W1971565607 @default.
• W3201248840 cites W1973480759 @default.
• W3201248840 cites W1984346385 @default.
• W3201248840 cites W1989274511 @default.
• W3201248840 cites W1997332384 @default.
• W3201248840 cites W2005028667 @default.
• W3201248840 cites W2007389916 @default.
• W3201248840 cites W2023486920 @default.
• W3201248840 cites W2033182743 @default.
• W3201248840 cites W2045125560 @default.
• W3201248840 cites W2049289548 @default.
• W3201248840 cites W2064667282 @default.
• W3201248840 cites W2071137113 @default.
• W3201248840 cites W2078379881 @default.
• W3201248840 cites W2091369856 @default.
• W3201248840 cites W2095519862 @default.
• W3201248840 cites W2104109863 @default.
• W3201248840 cites W2110003880 @default.
• W3201248840 cites W2110401273 @default.
• W3201248840 cites W2117488121 @default.
• W3201248840 cites W2120786099 @default.
• W3201248840 cites W2134918295 @default.
• W3201248840 cites W2135478926 @default.
• W3201248840 cites W2140888027 @default.
• W3201248840 cites W2149450071 @default.
• W3201248840 cites W2151523540 @default.
• W3201248840 cites W2164388472 @default.
• W3201248840 cites W2165579423 @default.
• W3201248840 cites W2333986897 @default.
• W3201248840 cites W2490318345 @default.
• W3201248840 cites W2594556919 @default.
• W3201248840 cites W2738055145 @default.
• W3201248840 cites W2741789802 @default.
• W3201248840 cites W2750784726 @default.
• W3201248840 cites W2761909673 @default.
• W3201248840 cites W2784344699 @default.
• W3201248840 cites W2795886244 @default.
• W3201248840 cites W2918640571 @default.
• W3201248840 cites W2919763925 @default.
• W3201248840 cites W2936339186 @default.
• W3201248840 cites W2946254369 @default.
• W3201248840 cites W2954481589 @default.
• W3201248840 cites W2990473506 @default.
• W3201248840 cites W3016554623 @default.
• W3201248840 cites W3080574299 @default.
• W3201248840 cites W3085973574 @default.
• W3201248840 cites W3088527014 @default.
• W3201248840 cites W3157419554 @default.
• W3201248840 doi "https://doi.org/10.1371/journal.pmed.1003801" @default.
• W3201248840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8496799" @default.
• W3201248840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34555025" @default.
• W3201248840 hasPublicationYear "2021" @default.
• W3201248840 type Work @default.
• W3201248840 sameAs 3201248840 @default.
• W3201248840 citedByCount "8" @default.
• W3201248840 countsByYear W32012488402021 @default.
• W3201248840 countsByYear W32012488402022 @default.
• W3201248840 countsByYear W32012488402023 @default.
• W3201248840 crossrefType "journal-article" @default.
• W3201248840 hasAuthorship W3201248840A5010335262 @default.
• W3201248840 hasAuthorship W3201248840A5025485223 @default.
• W3201248840 hasAuthorship W3201248840A5041882778 @default.
• W3201248840 hasAuthorship W3201248840A5058392597 @default.
• W3201248840 hasBestOaLocation W32012488401 @default.
• W3201248840 hasConcept C118552586 @default.
• W3201248840 hasConcept C120665830 @default.
• W3201248840 hasConcept C121332964 @default.
• W3201248840 hasConcept C126322002 @default.
• W3201248840 hasConcept C144024400 @default.
• W3201248840 hasConcept C149923435 @default.
• W3201248840 hasConcept C151730666 @default.
• W3201248840 hasConcept C187212893 @default.
• W3201248840 hasConcept C2779134260 @default.
• W3201248840 hasConcept C2779159551 @default.
• W3201248840 hasConcept C2779343474 @default.
• W3201248840 hasConcept C2779483572 @default.
• W3201248840 hasConcept C2908647359 @default.
• W3201248840 hasConcept C44249647 @default.
• W3201248840 hasConcept C61511704 @default.
• W3201248840 hasConcept C71924100 @default.
• W3201248840 hasConcept C74909509 @default.
• W3201248840 hasConcept C86803240 @default.
• W3201248840 hasConcept C99454951 @default.
• W3201248840 hasConceptScore W3201248840C118552586 @default.
• W3201248840 hasConceptScore W3201248840C120665830 @default.
• W3201248840 hasConceptScore W3201248840C121332964 @default.

• next